The female menopause--now and in the millennium: new treatment options for a better quality of life.
Estrogen has traditionally been the only agent effective for the prevention and treatment of post-menopausal osteoporosis. Estrogen's positive effects are often outweighed by negative ones. Newer agents provide safer alternatives that should increase compliance and improve quality of life.
Cefalu
C A
CA
Department of Family Medicine, Louisiana State University Medical Center, New Orleans, La., USA.
Fontenot
C
C
D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D011374:Progesterone / Q000627:therapeutic use; D011788:Quality of Life; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D011374:Progesterone; D002116:Calcitonin